{"identifier":"nobleid:/w1/20260522/FC837726","arkIdentifier":"ark:/48914/w1/20260522/FC837726","version":1,"workTitle":"Afatinib vs erlotinib for second-line treatment of Chinese patients with advanced squamous cell carcinoma of the lung.","workType":"Journal Article","authors":"Shun Lu, Wei Li, Caicun Zhou, Cheng-Ping Hu, Shukui Qin, Gang Cheng, Jifeng Feng, Jie Wang, Agnieszka Cseh, Barbara Peil","description":null,"workUrl":null,"existingDoi":"10.2147/OTT.S161506","createdAt":"2026-05-22T22:40:03.185546Z","canonicalUrl":"https://nobleid.org/ark:/48914/w1/20260522/FC837726.v1"}